Status:
COMPLETED
BAR-trial: Bioavailability of Ethanol Following Bariatric Surgery
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Conditions:
Obesity, Morbid
Eligibility:
All Genders
18-60 years
Brief Summary
The first-pass metabolism (FPM) is a barrier to the toxicity of ethanol. Changes to the size and function of the stomach may alter FPM. Bariatric surgery, like the gastric bypass procedure, involves s...
Eligibility Criteria
Inclusion
- volunteers from Central Norway
- morbid obese BMI \> 40 kg/m2)
- morbid obese BMI \> 35 kg/m2 given a obesity related disease that qualifies for bariatric surgery
Exclusion
- previous or current alcohol abuse
- risk for alcohol harm as assessed by AUDIT
- alcohol abstinence
- liver disease except fatty liver, which occurs in more than 50% of those who seek bariatric surgery
- previous colon resection
- not/insufficiently able to informed consent
- drugs that interact with alcohol dehydrogenase
- drugs that slow down emptying of the stomach
- pregnancy
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01840020
Start Date
September 1 2013
End Date
February 1 2020
Last Update
February 26 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sykehuset Namsos
Namsos, Norway
2
Obesity policlinic of St. Olavs Hospital
Trondheim, Norway